Concept information
Preferred term
Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Narrower concepts
- Aflibercept
- Axitinib (substance)
- Bevacizumab (substance)
- Brolucizumab (substance)
- Cabozantinib (substance)
- Lenvatinib
- Lenvatinib mesylate (substance)
- Pazopanib hydrochloride (substance)
- Pazopanib (substance)
- Pegaptanib sodium (substance)
- Pegaptanib (substance)
- Ramucirumab
- Ranibizumab (substance)
- Regorafenib
- Sorafenib (substance)
- Sorafenib tosylate (substance)
- Sunitinib malate (substance)
- Sunitinib (substance)
- Vandetanib (substance)
In other languages
URI
http://www.irandoc.acir/onto/irandoc/786910006
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}